Approach
Translate. Validate. Deploy.
We are building a non-chemical appetite regulation platform by translating a proven stimulation method into a scalable wearable and validating it with modern engineering and measurement discipline.
This is applied physiology, executed as technology.
1) Signal origin
The foundation of Satiogenix™ is a hunger-control method developed and refined over more than three decades of real-world clinical use.
Over that period, the approach has been applied to more than 400,000 clients across 30+ years of nationwide practice. A specific, non-invasive stimulation protocol consistently reduced appetite, leading to long-term practitioner adoption and patent protection.
That operating history defines the signal. Our work is to engineer it into a scalable, device-based system.
2) IP posture
The core method is protected by issued patent coverage relating to non-invasive stimulation and application protocols for appetite regulation.
Satiogenix™ holds an exclusive commercial license to this intellectual property.
The IP establishes the foundational method. Our advantage is extending that protection into device architecture, control logic, and data-driven refinement.
3) Translation to a wearable
Our primary technical task is translation.
We are converting a practitioner-applied protocol into a device-defined system with precise, repeatable parameters. This includes stimulus characteristics, placement constraints, timing logic, and safety boundaries.
Design priorities:
- Passive use with minimal user interaction
- High consistency across sessions and users
- Manufacturability and long-term wearability
- Compatibility with continuous data capture
The wearable is not an accessory to a program. It is the product.
4) Validation roadmap
Validation is structured, staged, and outcome-driven.
We begin with short-horizon appetite and craving metrics, then progress toward longer-term endpoints as the device stabilizes.
Roadmap:
- Signal confirmation: demonstrate consistent appetite suppression under controlled conditions
- Effect sizing: quantify magnitude and durability across users
- Reproducibility: confirm results across iterations and cohorts
Claims follow data. Expansion follows results.
5) Regulatory and claims posture
Satiogenix™ is building with regulatory reality in mind from day one.
Initial positioning is wellness-aligned, with clear boundaries on claims and language. Device design, data collection, and validation are structured to preserve optionality for future regulatory pathways if warranted.
We plan around regulation. We do not rely on ambiguity.
Who we work with
We collaborate with people who build and evaluate real systems.
- Wearable and medical device architects
- Obesity medicine and neuroendocrine experts
- Clinical study designers and regulatory professionals
Engagements are focused, time-boxed, and outcome-oriented.
Email an introWhat we share
With qualified partners and investors, we provide:
- Validation plan and milestones
- IP and licensing overview
- Technical architecture and translation logic
Detailed materials are shared selectively.
Back to HomeClosing
Satiogenix™ is an early-stage company building a non-chemical appetite regulation platform.
Our focus is execution, measurement, and defensible technology.